Canada markets open in 3 hours 45 minutes

Surgalign Holdings, Inc. (SRGA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.8900-1.1100 (-18.50%)
At close: 04:00PM EDT
4.9300 +0.04 (+0.82%)
After hours: 07:56PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close6.0000
Open5.2600
Bid0.0000 x 900
Ask0.0000 x 800
Day's Range4.5100 - 5.2600
52 Week Range2.9500 - 48.6000
Volume167,693
Avg. Volume103,844
Market Cap32.391M
Beta (5Y Monthly)2.16
PE Ratio (TTM)N/A
EPS (TTM)-14.8540
Earnings DateNov 07, 2022 - Nov 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est27.33
  • GlobeNewswire

    Surgalign Announces Global Settlement Agreement with Resolve Surgical Technologies and RTI Surgical, Inc.

    Parties enter into new sole-source supply relationship, extended for two yearsDEERFIELD, Ill., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that effective August 5, 2022, the Company entered into a global settlement agreement with Pioneer Surgical Technology, Inc. d/b/a Resolve Surgical Technologies and RTI Surgical, Inc. (togethe

  • GlobeNewswire

    Surgalign Holdings, Inc. Announces Second Quarter 2022 Results and Reiterates Full Year 2022 Revenue Guidance Range

    DEERFIELD, Ill., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced financial results for its 2022 second quarter ended June 30, 2022. 2022 Second Quarter Key Highlights and Subsequent Events: First successful surgical procedures utilizing the HOLO Portal™ Surgical Guidance System in Indiana and further expansion in Ohio with more site

  • GlobeNewswire

    Surgalign Names Paolo Amoruso Chief Legal Officer and Corporate Secretary

    DEERFIELD, Ill., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced the appointment of Paolo Amoruso as its new General Counsel and Corporate Secretary, effective August 1, 2022. He previously served as Interim General Counsel of Surgalign, having joined the Company in April 2022. Commenting on today’s appointment, Terry Rich, President